AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2013
Dec 4, 2013
34395_dirs_2013-12-04_7e74c2eb-fe89-404f-a437-bcab2923d912.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2013-11-25
Reporting Person: Innes Guy Archibald (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-25 | COMMON STOCK | P | 132246 | $271102.7 | Acquired | 1064341 | Direct |
| 2013-12-02 | COMMON STOCK | P | 4878 | $9999.9 | Acquired | 1069219 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-25 | WARRANT | $2.4 | P | 132246 | Acquired | 2018-11-25 | COMMON STOCK (132246) | Direct |
Footnotes
F1: A total of 132,246 Units (1 Unit = 1 common share + 1 warrant to purchase 1 common share) were acquired on November 25, 2013, of which 121,952 Units were purchased at a cost basis of $2.05 per Unit and 10,294 Units were acquired pursuant to the settlement of an existing debt between the Company and Guy Archibald Innes valued at $21,102.70.
F2: The 4,878 shares were purchased at a cost basis of $2.05 per share.
More from VOLITIONRX LTD
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 1